(Q33978978)

30 July 2017

title

Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California (English)

1 reference

30 July 2017

0 references

0 references

3

1 reference

30 July 2017

4

Brian Edlin

1 reference

30 July 2017

Kimberly Page

11

0 references

Michael P. Busch

10

object named as

Michael P Busch

1 reference

30 July 2017

2

Judith A Hahn

1 reference

30 July 2017

Paulo Telles Dias

1

1 reference

30 July 2017

Jeff Martin

5

1 reference

30 July 2017

Paula Lum

6

1 reference

30 July 2017

Jennifer Evans

7

1 reference

30 July 2017

Alex Kral

8

1 reference

30 July 2017

Steve Deeks

9

1 reference

30 July 2017

publication date

2 August 2011

1 reference

30 July 2017

published in

BMC Infectious Diseases

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

page(s)

208

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2334-11-208

30 July 2017

exact match

0 references

cites work

Hepatitis C virus genotypes in clinical specimens tested at a national reference testing laboratory in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Challenges for rapid molecular HIV diagnostics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Hepatitis C vaccine: supply and demand

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: a multilevel analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

HIV among injection drug users in large US metropolitan areas, 1998

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

HIV risk behaviors in African-American drug injector networks: implications of injection-partner mixing and partnership characteristics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

The natural history of hepatitis C virus infection: host, viral, and environmental factors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Clinical significance of hepatitis C virus genotypes and quasispecies.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Hepatitis C virus infection in the United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Characterization of anti-hepatitis C virus-positive sera not genotyped by restriction fragment length polymorphism or serology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3199778

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Differences in treatment outcome for hepatitis C among ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Changing HCV genotypes distribution in Poland--relation to source and time of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Injection drug users in the United States, 1979-2002: an aging population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Evaluation of a new-generation line-probe assay that detects 5' untranslated and core regions to genotype and subtype hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Frequent hepatitis C virus superinfection in injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Multiple infections with different HCV genotypes: prevalence and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-208

Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21810243

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2334-11-208

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference